A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and 'in vivo' evaluation

被引:44
作者
Wang, Lei [1 ]
Tang, Xing [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang 110016, Peoples R China
关键词
ketoconazole; bioadhesion; swelling; vaginal tablets; effervescent;
D O I
10.1016/j.ijpharm.2007.08.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioadhesive tablet formulations of ketoconazole for vaginal delivery were studied. Carbomer (Carbopol 974P, Carbopol 934P), hydroxypropylmethyl cellulose (HPMC) and hydroxypropyl cellulose (HPC) were used as candidate bioadhesive polymers. Effervescent was incorporated into the formulations as a disintegration agent. The swelling behavior and bioadhesive strength of the drug-free tablets were investigated. Carbopol 934P was selected as biopolymer in combination with HPMC or HPC at different ratios to develop five drug-loaded formulations. The swellings, tackiness and in vitro release were studied on the tablets. A good sustained effect and a moderate bioadhesion were obtained with the tablets. The formulation containing 100 mg of effervescent, with the Carbopol 934P:HPC ratio of 1:9, seemed to be the optimum one for the tablet. In vivo drug residence tests were carried out by administering the preferred formulation to female rats. The results showed that the drug remaining followed a one-order model. Even after 24h of administration in vagina of rats, 17% of the original employed drug was retained on the vaginal tissue. Our study may provide a potential vaginal tablet formulation of ketoconazole against Candida albicans. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 18 条
  • [1] Mucoadhesive drug delivery systems
    Shaikh, Rahamatullah
    Singh, Thakur Raghu Raj
    Garland, Martin James
    Woolfson, A. David
    Donnelly, Ryan F.
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2011, 3 (01): : 89 - 100
  • [2] Baloglu E., 2003, Farmaco (Lausanne), V58, P391, DOI 10.1016/S0014-827X(03)00044-2
  • [3] DEVELOPMENT AND TESTING OF BIOADHESIVE, FLUORIDE-CONTAINING SLOW-RELEASE TABLETS FOR ORAL USE
    BOTTENBERG, P
    CLEYMAET, R
    DEMUYNCK, C
    REMON, JP
    COOMANS, D
    MICHOTTE, Y
    SLOP, D
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (07) : 457 - 464
  • [4] Characterization and in vitro dissolution behaviour of ketoconazole/beta- and 2-hydroxypropyl-beta-cyclodextrin inclusion compounds
    EsclusaDiaz, MT
    GuimaraensMendez, M
    PerezMarcos, MB
    VilaJato, JL
    TorresLabandeira, JJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 143 (02) : 203 - 210
  • [5] Vaginal candidosis: epidemiological and etiological factors
    Ferrer, J
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 : S21 - S27
  • [6] BIOADHESIVE INTRAORAL RELEASE SYSTEMS - DESIGN, TESTING AND ANALYSIS
    GURNY, R
    MEYER, JM
    PEPPAS, NA
    [J]. BIOMATERIALS, 1984, 5 (06) : 336 - 340
  • [7] GURSOY A, 1989, STP PHARM, V5, P886
  • [8] Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation
    Ikinci, G
    Senel, S
    Wilson, CG
    Sumnu, M
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) : 173 - 178
  • [9] Karasulu H. Yesim, 2004, Farmaco (Lausanne), V59, P163
  • [10] Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery
    Karasulu, HY
    Taneri, F
    Sanal, E
    Güneri, T
    Ertan, G
    [J]. JOURNAL OF MICROENCAPSULATION, 2002, 19 (03) : 357 - 362